Strata Critical Medical, Inc. Income Statement
SRTA|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
Strata Critical Medical, Inc. reported $147M in revenue and $27M in net loss for FY2025. Revenue has grown at a 47.3% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $146.8M | $225.2M | $146.1M | $50.5M | $31.2M |
| Cost of Revenue | $117.2M | $183.1M | $123.8M | $40.0M | $26.5M |
| Gross Profit | $29.6M | - | - | - | - |
| SG&A Expense | $50.9M | $95.2M | $62.5M | $30.1M | $10.5M |
| Operating Income | -$22.5M | -$68.1M | -$53.5M | -$24.1M | -$11.5M |
| Interest Expense | - | $8.4M | $3.4M | $460.0K | $703.0K |
| Income Tax | $0 | -$1.5M | -$772.0K | -$3.6M | $0 |
| Net Income | -$27.3M | -$56.1M | -$27.3M | -$40.1M | -$10.8M |
| EPS (Basic) | -$0.35 | -$0.76 | -$0.38 | -$0.93 | -$0.43 |
| EPS (Diluted) | -$0.35 | -$0.76 | -$0.38 | -$0.93 | -$0.43 |
| Shares Outstanding | 77.5M | 73.5M | 71.2M | 42.9M | 25.3M |
| Gross Margin | 20.2% | - | - | - | - |
| Operating Margin | -15.3% | -30.3% | -36.6% | -47.7% | -37.0% |
| Profit Margin | -18.6% | -24.9% | -18.7% | -79.3% | -34.7% |